Shenzhen Neptunus Interlong Bio-technique Company Limited (HKG:8329)

Market Cap	266.80M +5.3%
Revenue (ttm)	1.09B -5.8%
Net Income	6.76M -80.8%
EPS	0.00 -80.8%
Shares Out	1.68B
PE Ratio	39.45
Forward PE	n/a
Dividend	0.01 (3.34%)
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	832,500
Open	n/a
Previous Close	0.1610
Day's Range	n/a
52-Week Range	0.0828 - 0.3800
Beta	-0.29
RSI	48.90
Earnings Date	Nov 21, 2025

About HKG:8329

Shenzhen Neptunus Interlong Bio-technique Company Limited, together with its subsidiaries, engages in the research and development, manufacturing, and selling of medicines and medical devices in the People’s Republic of China. The company offers medicines for various therapeutic areas, including oncology, cardiovascular system, respiratory system, digestive system, and mental disorders. It also involved in the purchase, sale, and distribution of medicines and healthcare food products; and research and development of biological technology busine...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2002
• Employees: 1,474
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 8329

Financial Performance

In 2024, HKG:8329's revenue was 1.04 billion, a decrease of -2.18% compared to the previous year's 1.06 billion. Earnings were 25.01 million, an increase of 3.68%.

Financial numbers in CNY